Providers Coverage Costs Reference

51/51 states verified · 14/25 providers audited

Medicaid coverage

West Virginia: what Medicaid covers

West Virginia has no weight-loss or anti-obesity class at all. It files the two drugs under the condition instead: Wegovy sits under major adverse cardiovascular event reduction and under metabolic dysfunction-associated steatohepatitis, Zepbound under obstructive sleep apnea, and each class carries its own prior authorization criteria. Saxenda is not named.

Checked against the primary source August 28, 2026
What Medicaid in West Virginia covers, and the criteria that apply.
Drug Position Criteria
Semaglutide Other indications only Wegovy appears only under the cardiovascular event reduction class and the MASH class, both with prior authorization criteria
Tirzepatide Other indications only Zepbound appears only under the obstructive sleep apnea class, with prior authorization criteria
Liraglutide not checked Saxenda is named nowhere on the preferred drug list, and the list has no weight-loss class
If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

  1. 1
    West Virginia Medicaid Preferred Drug List and Prior Authorization Criteria, effective April 1, 2026

    West Virginia Bureau for Medical Services, Office of Pharmacy Services Primary text read and checked Checked August 28, 2026